Optinose
  • Join Our Mission
  • Contact Us
  • Company
    • Our Purpose
    • Company History
    • Leadership Team
    • Board of Directors
    • Partnership Opportunities
    • Corporate Compliance
  • Exhalation
    Delivery Systems
    • Liquid Delivery
    • Powder Delivery Device
    • Anatomy of the Nasal Passages
    • Nasal Delivery Challenges
  • Therapeutic
    Areas
  • Products
    • XHANCE™
    • ONZETRA® Xsail®
  • Research &
    Development
    • XHANCE™ - Future Development
    • OPN-300
    • OPN-021
    • Partnerships
  • Investors
    • News & Events
    • Stock Information
    • Corporate Governance
    • SEC Filings
    • Proxy Materials
    • Investor Resources
  • News &
    Media
  • Scientific
    Communications
    • Peer-Reviewed Journal Publications

Proxy Materials


Title
Annual Report on Form 10K
Download Documentation 
2018 Proxy Statement
Download Documentation 

Investors

  • News & Events
  • Stock Information
  • Corporate Governance
  • SEC Filings
  • Proxy Materials
  • Investor Resources

Toolkit

  • Printer Friendly Version Print page
  • E-mail this page Email this page
  • E-mail Alerts Sign up for email alerts

  • Investor Contact

    Jonathan Neely
    VP Investor Relations and Business Operations
    Email: investors@optinose.com
Contact Us
Join Our Mission
Privacy Policy
Terms of Use
Site Map
Footer Logo
©2017 OptiNose US, Inc. OPTINOSE-17-013a 09/2017